drugset / Trial / NCT07086079
A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)
NaSingle-groupOpen-labelBasic science
Summary
The goal of this study is to learn what happens to doravirine (DOR) and islatravir (ISL) in a healthy lactating female's body over time. Researchers want to learn if DOR and ISL are in breast milk.
Timeline
- Start
- 2025-09-26
- Primary completion
- 2025-12-08
- Completion
- 2026-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doravirine | Small molecule | — | Oral |
| Subject | Islatravir | Other / unclassified | — | Oral |
Indications
No indication recorded.